ESR1 and breast carcinoma: Next, we performed analyses of latent splicing activation comparing data from two different breast cell lines having different phenotypes: the immortalized, non-transformed mammary epithelial cell line MCF-10 A and the MCF-7 breast carcinoma cell line, which is expressing the estrogen receptor (ER) (38).